Literature DB >> 17571248

IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells.

Rosario Amato1, Miranda Menniti, Valter Agosti, Rosalia Boito, Nicola Costa, Heather M Bond, Vito Barbieri, Pierosandro Tagliaferri, Salvatore Venuta, Nicola Perrotti.   

Abstract

The interleukin-2 is a cytokine that is essential for lymphocytic survival and function. Ectopic expression of the IL-2 receptor in epithelial tissues has been reported previously, although the functional significance of this expression is still being investigated. We provided novel structural and functional information on the expression of the IL-2 receptor in kidney cancer cells and in other normal and neoplastic human epithelial tissues. In A-498 kidney cancer cells, we showed that IL-2 binding to its own receptor triggers a signal transduction pathway leading to the inhibition of proliferation and apoptosis. We found that the inhibition of proliferation is associated with Erk1/2 dephosphorylation, whereas the survival signals appear to be mediated by Sgk1 activation. This investigation focuses on the IL-2 induced regulation of Sgk1 and describes a role of the IL-2 receptor and Sgk1 in the regulation of epithelial tumor cell death and survival.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17571248     DOI: 10.1007/s00109-007-0205-2

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  53 in total

1.  Uncoupling of promitogenic and antiapoptotic functions of IL-2 by Smad-dependent TGF-beta signaling.

Authors:  Brad H Nelson; Timothy P Martyak; Lucas J Thompson; James J Moon; Tongwen Wang
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

Review 2.  Nucleocytoplasmic transport in apoptosis.

Authors:  E Ferrando-May
Journal:  Cell Death Differ       Date:  2005-10       Impact factor: 15.828

3.  Induction of tumor cell apoptosis via Fas/DR5.

Authors:  Wenzhu Li; Shengyu Wang; Caixia Chen; Guohong Zhuang
Journal:  Cell Mol Immunol       Date:  2006-12       Impact factor: 11.530

4.  Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.

Authors:  D David; L Bani; J L Moreau; M P Treilhou; T Nakarai; M Joussemet; J Ritz; B Dupont; G Pialoux; J Thèze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

Review 5.  New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure.

Authors:  Volker Vallon; Florian Lang
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-01       Impact factor: 2.894

6.  IL-2 and related cytokines can promote T cell survival by activating AKT.

Authors:  Erin Kelly; Angela Won; Yosef Refaeli; Luk Van Parijs
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

7.  Differential regulation of the expression of interleukin-2 receptor gamma-chain during the in vitro differentiation of human myeloid cells.

Authors:  G Morrone; H M Bond; C Cuomo; V Agosti; A Petrella; A M Pagnano; A Della Corte; O Marasco; S Venuta
Journal:  Biochem J       Date:  1995-06-15       Impact factor: 3.857

8.  sgk: an essential convergence point for peptide and steroid hormone regulation of ENaC-mediated Na+ transport.

Authors:  Carla J Faletti; Nicola Perrotti; Simeon I Taylor; Bonnie L Blazer-Yost
Journal:  Am J Physiol Cell Physiol       Date:  2002-03       Impact factor: 4.249

9.  p53 stimulates promoter activity of the sgk. serum/glucocorticoid-inducible serine/threonine protein kinase gene in rodent mammary epithelial cells.

Authors:  A C Maiyar; A J Huang; P T Phu; H H Cha; G L Firestone
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

10.  IL-2 and IL-15 receptor alpha-subunits are coexpressed in a supramolecular receptor cluster in lipid rafts of T cells.

Authors:  György Vámosi; Andrea Bodnár; György Vereb; Attila Jenei; Carolyn K Goldman; Jörg Langowski; Katalin Tóth; László Mátyus; János Szöllösi; Thomas A Waldmann; Sándor Damjanovich
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

View more
  20 in total

1.  Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway.

Authors:  Donggon Lyo; Limei Xu; David A Foster
Journal:  Biochem Biophys Res Commun       Date:  2010-05-08       Impact factor: 3.575

Review 2.  SGK1 survival through various lives may save us all.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2007-07       Impact factor: 4.599

Review 3.  Serum- and glucocorticoid-inducible kinase 1 in the regulation of renal and extrarenal potassium transport.

Authors:  Florian Lang; Volker Vallon
Journal:  Clin Exp Nephrol       Date:  2011-11-01       Impact factor: 2.801

4.  PDCD5 inhibits progression of renal cell carcinoma by promoting T cell immunity: with the involvement of the HDAC3/microRNA-195-5p/SGK1.

Authors:  Shu-Cheng Liu; Li-Bo Chen; Ping-Feng Chen; Meng-Long Huang; Tian-Pei Liu; Jun Peng; Xin-Sheng Lu
Journal:  Clin Epigenetics       Date:  2022-10-20       Impact factor: 7.259

Review 5.  Targeting SGK1 in diabetes.

Authors:  Florian Lang; Agnes Görlach; Volker Vallon
Journal:  Expert Opin Ther Targets       Date:  2009-11       Impact factor: 6.902

Review 6.  Enhancing mTOR-targeted cancer therapy.

Authors:  Xuerong Wang; Shi-Yong Sun
Journal:  Expert Opin Ther Targets       Date:  2009-10       Impact factor: 6.902

7.  Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation.

Authors:  Rosario Amato; Lucia D'Antona; Giovanni Porciatti; Valter Agosti; Miranda Menniti; Cinzia Rinaldo; Nicola Costa; Emanuele Bellacchio; Stefano Mattarocci; Giorgio Fuiano; Silvia Soddu; Marco G Paggi; Florian Lang; Nicola Perrotti
Journal:  J Mol Med (Berl)       Date:  2009-09-11       Impact factor: 4.599

Review 8.  The physiological impact of the serum and glucocorticoid-inducible kinase SGK1.

Authors:  Florian Lang; Ferruh Artunc; Volker Vallon
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-09       Impact factor: 2.894

9.  Low SGK1 expression in human adrenocortical tumors is associated with ACTH-independent glucocorticoid secretion and poor prognosis.

Authors:  Cristina L Ronchi; Silviu Sbiera; Ellen Leich; Frédérique Tissier; Sonja Steinhauer; Timo Deutschbein; Martin Fassnacht; Bruno Allolio
Journal:  J Clin Endocrinol Metab       Date:  2012-10-09       Impact factor: 5.958

10.  Systems Biomedicine of Primary and Metastatic Colorectal Cancer Reveals Potential Therapeutic Targets.

Authors:  Mehran Piran; Neda Sepahi; Afagh Moattari; Amir Rahimi; Ali Ghanbariasad
Journal:  Front Oncol       Date:  2021-06-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.